ArticleChinese medicine2026
NMR-based metabolomics in a clinical cohort: deciphering the metabolic characteristics of gout with the dampness-heat syndrome and elucidate the efficacy of Simiao Pill.
Article in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundGout is an inflammatory arthritis caused by purine metabolism disorders. The gout with the dampness-heat syndrome (GDHS) is a common Traditional Chinese Medicine (TCM) syndrome in this kind of disease, yet its modern scientific basis remains poorly understood. Simiao Pill (SMP), a classic formula in treating GDHS, has an unclear mechanism of action.
methodsWe conducted a targeted Nuclear Magnetic Resonance (NMR)-based metabolomic analysis on serum and urine samples from 197 GDHS patients and 101 healthy controls. Multiple machine learning algorithms, including support vector machine (SVM), random forest (RF), and least absolute shrinkage and selection operator (LASSO), were employed to identify potential biomarkers for GDHS. The Apriori algorithm was applied to uncover associations between TCM syndrome manifestations and metabolomic biomarkers. A subgroup of 50 GDHS patients received a 4-week SMP treatment, and their metabolomic profiles were compared pre- and post- intervention.
resultsGDHS patients exhibited a significant remodeled metabolome, characterized by disruptions in pyruvate, amino acid metabolism, and energy metabolism. A panel of 12 biomarkers with high diagnostic power was identified. Association rule mining further highlighted triglycerides and glycine as central nodes showing extensive connections to TCM syndromes. SMP intervention significantly reversed the level of 10 biomarkers (e.g., citrate, glycine, lactate), effectively normalizing perturbations in glycolysis/gluconeogenesis, the tricarboxylic acid cycle, and glycine/serine/threonine metabolism, and lipid homeostasis.
conclusionThis real-world clinical study systematically delineates the metabolic features of GDHS, innovatively linking TCM syndromes to specific metabolic disturbances. It confirms that SMP exerts its therapeutic effects through multi-targeted modulation of the metabolic network. This work provides a new scientific paradigm for the study of "disease-syndrome-treatment" in TCM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.